Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications
This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...
808 Views
Samsung Biologics: Regulators Crack Down On Its Accounting
After the market close today, the Korean regulators (Financial Services Commission) made a major negative announcement on Samsung Biologics Co.,...
467 Views
Korea Stock Market Monthly Recap #26 (June 2018)
"Sell in May and Go Away" continued its trend in the Korea Stock Market in June. Since end of April, KOSPI is down 7.5% in terms of Won and it is...
177 Views
Biogen Exercises Samsung Bioepis Call Option - Summary & Implications
Samsung Biologics Co., Ltd (207940 KS) said in a regulatory filing that Biogen Inc (BIIB US) exercised Bioepis call option. Link of this...
259 Views
The Week That Was In North Asia@Smartkarma: Won Depreciation, Mercari, & 11st Spin-Off & Investment
It has been an eventful week in North Asia. The biggest story was the hugely successful IPO of Mercari in Japan. In Korea, SK Telecom continued its...
131 Views